Last reviewed · How we verify
NCT05618431: NIPT
Validate Non-invasive Prenatal Tests for the Detection of Chromosomal Abnormalities
NA trial testing NIPT in Validation of New Test NIPT in 1,790 participants. Status unknown.
1 June 2024
Quick facts
| Lead sponsor | CerbaXpert |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 1,790 |
| Start date | 1 February 2023 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 June 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- NIPT
Conditions studied
- Validation of New Test NIPT — all drugs for Validation of New Test NIPT →
Sponsor
CerbaXpert
Who can join
Adults 18 to 50, female only, with Validation of New Test NIPT. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will be conducted on pregnant patients for whom there is a suspicion of a chromosomal abnormality of the fetus. These are patients eligible for non-invasive prenatal screening as part of their usual pregnancy surveillance. This research aims to develop and validate a new method for non-invasive prenatal testing. This prospective collection study will allow the collection of biological samples necessary for the development, testing and validation of these new tests
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05618431
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of NIPT
Trials testing the same drug.
- NCT06089746 — Lumbosacral Spinal Stenosis - Non-Invasive Postural Therapy for Older Adult Veterans · NA · recruiting
- NCT05798858 — A Pilot Study for Implementation of First Trimester Screening of Aneuploidies in Campania Region · NA · unknown
- NCT04595201 — Clinical Follow-up of Pregnant Subjects Undergoing NIPT · recruiting
- NCT04437992 — Feasibility Study of a New Screening Program for Major Aneuploidies (T21, T18, T13) in the Emilia-Romagna Region (SAPERE · unknown
- NCT04049604 — IDENTIFY Study: Natural History of Maternal Neoplasia · NA · recruiting
Other CerbaXpert trials
Trials by the same sponsor.
- NCT06144333 — Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters C · NA · not yet recruiting
- NCT05983679 — Prevalence of Sexually Transmitted Infections (STIs) and Coinfections in the General Population · not yet recruiting
- NCT06623058 — Accupower ® HCV Performance Evaluation Quant Kit Bioneer Existation™FA 96/384 · not yet recruiting
- NCT06623071 — Accupower ® HBV Performance Evaluation Quant Kit Bioneer Existation FA 96/384 · recruiting
- NCT06373510 — Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05618431 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by CerbaXpert
- Last refreshed: 6 December 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05618431.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing